7,025
Views
66
CrossRef citations to date
0
Altmetric
State of the Art Reviews

Kidney injury molecule-1 in kidney disease

&
Pages 1567-1573 | Received 09 Feb 2016, Accepted 12 May 2016, Published online: 19 Oct 2016
 

Abstract

Kidney injury molecule-1(KIM-1) is a type I membrane protein, comprising an extracellular portion and a cytoplasmic portion, which is expressed at very low levels in the normal kidney. The extracellular portion can cleave and rapidly enter tubule lumens after kidney injury, and can then be detected in the urine. It has been confirmed that the urine KIM-1 level is closely related to tissue KIM-1 level and correlated with kidney tissue damage. Not only is KIM-1 proven to be an early biomarker of acute kidney injury but it also has a potential role in predicting long-term renal outcome. This review summarizes the relationships between KIM-1 and kidney injury, especially in chronic kidney disease.

Disclosure statement

The authors declare that they have no conflict of interest. The article was published in “Chinese Journal of Clinical Medicine”, in Chinese language.

Funding

This study was funded by the National Natural Science Foundation of China (81270408, 81570666), Chinese Society of Nephrology (13030300415), Jiangsu Province’s Key Provincial Talents Program (RC201162), Six Major Talents Summit of Jiangsu Province (2010(IB10)), The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.